RecruitingSpinal Cord Injury (SCI)Neurogenic Bladder (NB)
Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury
Eligible age
18–75 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to determine the safety and efficacy of Injectrode Tibial Nerve Stimulation for bladder function in people with spinal cord injury.
Sponsor: The University of Texas Health Science Center, Houston
You may qualify if…
- ✓ Non-progressive chronic (\>1 year) SCI
- ✓ Neurologic level of injury T9 and above
- ✓ Stable over active bladder (OAB) medications (≥3 months)
- ✓ No contraindication to MRI (per MRI Safety Questionnaire)
- ✓ English or Spanish speaking
- ✓ Tolerate and be able to evoke toe flexion bilaterally with transcutaneous tibial nerve stimulation (tTNS) (self or assisted)
- ✓ Pass the tTNS competency checklist to perform or direct performance of tTNS.
You may not qualify if…
- ✕ Ongoing/active genitourinary oncologic diagnoses
- ✕ History of other central nervous system disorder (CNS) disorders and/or peripheral neuropathy
- ✕ Pregnancy or planning to become pregnant.
- ✕ Lower Motor Neuron bladder
- ✕ Restorative bladder surgery such as augmentation cystoplasty
- ✕ Botulinum toxin-A injections in the bladder within 6 months of trial enrolment (injection in other sites is allowed)
- ✕ Anticoagulation treatment or prophylaxis
- ✕ Advanced peripheral vascular disease (gangrene, amputation, etc.)
Where it's recruiting
Texas
Houston
Source: ClinicalTrials.gov · NCT07264868 · last updated 2026-05-11